Clinical Trial Update: Phase I Clinical Study of Chondroitin Sulfate for Treatment of NEC [Phase 1]

View source ↗

Summary

A Phase I study of chondroitin sulfate for treating Necrotizing Enterocolitis and intestinal ischemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intestinal Ischemia
• Necrotizing Enterocolitis

Drugs mentioned

• Chondroitin sulfate (chondroitin sulfate)

Snippet

Sponsor: Indiana University | Conditions: Necrotizing Enterocolitis, Intestinal Ischemia | Phase 1 | Status: WITHDRAWN